news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

reporter chen xing, editor duan lian, zhang haini

after the market closed on september 1, *st dayao (sh603963, share price 3.30 yuan, market value 725 million yuan, hereinafter referred to as dali pharmaceutical) announced thatthe company's actual controller, chairman and general manager yang junxiang was detained and investigatedthe announcement stated that the matter involving yang junxiang had nothing to do with the company, and as of the date of disclosure of this announcement, the company had not been asked by relevant authorities to assist in the investigation.

yang junxiang, 62, founded dali pharmaceutical in his early years. according to the company's 2024 semi-annual report, yang junxiang, yang qinglong, and yin cuixian directly hold 23.31%, 11.94%, and 3.06% of the company's shares respectively. yang qinglong is yang junxiang's son, and yin cuixian is yang junxiang's wife. in addition, yang junxiang's brother yang junwei holds 0.56% of the company's shares.

in early august this year, yang junxiang also sought to transfer the control of the listed company, but the plan was terminated after a few days. as of august 9, dali pharmaceutical had more than 17,000 shareholders.

the actual controller of dali pharmaceutical was detained for investigation

he quit politics at the age of 30 to go into business and was once very successful

the announcement shows that dali pharmaceutical and the family of yang junxiang, the actual controller, chairman and general manager, received a notice of detention and investigation of yang junxiang issued by the zhenkang county supervisory committee on august 31, 2024. the matters involved have nothing to do with the company. as of the date of the announcement, the company has not been asked by relevant authorities to assist in the investigation.